A Phase I Pilot Clinical Trial of Dose Escalation with Stereotactic-Guided Intraventricular Thrombolysis Using Tenecteplase (rhTNK-tPA) for Intraventricular Hemorrhage.

MLA

“A Phase I Pilot Clinical Trial of Dose Escalation with Stereotactic-Guided Intraventricular Thrombolysis Using Tenecteplase (RhTNK-TPA) for Intraventricular Hemorrhage.” Clinical Trials Week, Feb. 2025, p. 90. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=183166637&authtype=sso&custid=ns315887.

APA

A Phase I Pilot Clinical Trial of Dose Escalation with Stereotactic-Guided Intraventricular Thrombolysis Using Tenecteplase (rhTNK-tPA) for Intraventricular Hemorrhage. (2025). Clinical Trials Week, 90.

Chicago

“A Phase I Pilot Clinical Trial of Dose Escalation with Stereotactic-Guided Intraventricular Thrombolysis Using Tenecteplase (RhTNK-TPA) for Intraventricular Hemorrhage.” 2025. Clinical Trials Week, February, 90. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=183166637&authtype=sso&custid=ns315887.